BIO Protocol (BIO)

As this bounce keeps building, AI narrative is starting to rotate again. I wouldn't be surprised to see liquidity chase three areas first: » Robots » Memory pooling » Custom chips These are some of the most beaten-down pockets of the AI trade, which is exactly why they can move the fastest once momentum flips and capital starts rotating. The next tier I'm watching is Nuclear energy & power, Biotech, CPUs and AI compute infrastructure / data centers The overlap is worth paying attention to. • @BioProtocol || $BIO • @vitadao || $VITA • @origin_trail $TRAC • @ResearchHub || $RSC • @ionet || $IO • @rendernetwork || $RNDR • @bittensor || $TAO • @AethirCloud || $ATH TradFi strength has a habit of bleeding into crypto narratives. When AI beta wakes up, on-chain AI tokens usually don't stay quiet for long. Some equities already catching bids over the past couple of sessions: Robots • $OUST - @ousterlidar • $BB - @BlackBerry • $AMBA - @Ambarella_Inc $ROBO - @FabricFND $AUKI - @AukiLabs Memory Pooling $MRVL, $ALAB and $CRDO Just sharing where I'm seeing flows pick up and where I'm paying the most attention.

OGAudit Web3 Research: @BioProtocol $BIO - The Binance Labs and Pfizer Ventures Backed DeSci Platform Where an AI Agent Raised $900K for Longevity Research? Bio Protocol has been building the financial layer for decentralized science since 2024 founded by the teams behind Molecule and VitaDAO, now integrating AI agents into the biotech research pipeline: - Bio enables global communities to create user owned research networks that fund and develop biotechnologies from day one with BioDAOs (VitaDAO for longevity, AthenaDAO for women’s health, HairDAO and others) raising capital via Ignition Sales, tokenizing IP into onchain assets and distributing research royalties to BIO stakers. - BioAgents, launched August 2025 are autonomous AI scientific agents trained on research data. The first Aubrai, trained on Aubrey de Grey’s longevity lab data, generated 1,000+ onchain hypotheses and raised $900,000 in research funding within weeks of launch. - Bio V2 (AI-native DeSci platform, funded by a $6.9M Maelstrom raise in September 2025) targets deeper AI integration for hypothesis generation, experimental design and automated R&D pipeline management. Is Binance Labs backing, $6.9M in fresh funding, a live AI bioagent raising $900K for longevity research and Pfizer Ventures ecosystem validation the most credible real world DeSci thesis in crypto or does extreme RSI volatility, an 80M BIO treasury dump, tokenized biotech IP facing an unproven regulatory landscape and 33% supply overhang confirm that BIO’s real value will only emerge when research royalties start flowing to token holders? Category: Biotech / AI Coin Name: $BIO Circulating Supply: 2.22B Market Cap: $63.47M Market Cap Rank: #316 OG (Trust) Score: 40.55 OG Score Rank: #129/1125 Reviewed by 10 OG Auditors. See the Social Audit with Reviews by crypto OG’s and more on the $BIO Coin page: ogaudit(.)com/crypto/bio-protocol-bio https://t.co/rPnwoObmCB

$BIO Decentralized science is a new sector that emerged in the late stage of the last bull market. I am personally quite bullish on this coin; it is a decentralized science platform token that has now also integrated with AI. Not only does the token have solid intrinsic value, but just looking at this chart pattern, the probability of a future pump is fairly high. As for when the pump will happen, this coin will definitely move in sync with Bitcoin. https://t.co/3YvzULy4SC

BIO ran +59.81% after making the Club AB Trading list. These are the moves we want on radar early. NFA. Results vary. https://t.co/GnWXaMSa9y

$BIO is always kind of a dumb narrative but the price has been ok the last day because of the OpenLabs announcement (below). Even still, the chart itself looks pretty meh to me and I'm not interested in firing in these current conditions. https://t.co/oqT1xxXNPQ https://t.co/MHF2BIRNuK

Spotlighting our expert reviews on: @BioProtocol Our OG expert reviewers note that BIO Protocol $BIO is attempting to merge decentralized governance with real world biotech funding, allowing communities to fund research, earn exposure to intellectual property stakes and influence which scientific projects receive capital. However, the token remains highly speculative with value heavily dependent on future ecosystem adoption rather than current revenue. High execution risk and complex incentive structures raise concerns about uneven control and long term sustainability. Can BIO turn community driven science funding into sustainable token demand or will long research timelines and speculative mechanics keep it dependent on narrative cycles? More on the OG audit review and the project info here: ogaudit(.)com/crypto/bio-protocol-bio https://t.co/rPnwoObmCB

In times of uncertainty, I like looking for 2 types of coins: Super under the radar ones (BIO, AKT, EIGEN right now, JTO, WLD, BP before they moved) OR cabal coins (Blife , Zerebro, arc, those types of coins). I find that those are the ones that move in bad conditions